Geron Corporation
GERN
|
$3.66
4.57%
2.5M
|
Health Technology
(0.0% 1d) (7.4% 1m) (44.6% 1y) (0.0% 2d) (-6.2% 3d) (-5.1% 7d) (26.43% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 2,001,558,452
http://www.geron.com
Sec Filling | Patents | 46 employees
(US) Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
msa
add to watch list Paper trade email alert is off
Press-releases
Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Published: 2024-03-19 (Crawled : 14:00) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 2.05%
H: 5.09%
C: 0.62%
million corporation offering
FDA Adcomm Backs Geron’s Anemia Drug for Blood Cancer
Published: 2024-03-15 (Crawled : 12:30) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 71.43%
H: 16.33%
C: 12.0%
fda drug anemia cancer blood
FDA Questions Benefit, Risk Profile of Geron’s MDS Candidate Ahead of Adcomm
Published: 2024-03-13 (Crawled : 12:30) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: -2.66%
H: 1.09%
C: -4.37%
fda candidate risk
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 0.48%
H: 4.55%
C: 0.0%
AKTX | $1.25 3.31% 1.2K
|
Health Technology
|
| O: 6.67%
H: 0.0%
C: -5.83%
drug antibody pipeline therapeutics agreement
Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:30) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 1.69%
H: 10.48%
C: -7.14%
business year corporation financial results
Geron to Participate in the B. Riley Securities Virtual Oncology Conference
Published: 2024-01-12 (Crawled : 18:00) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 2.49%
H: 2.91%
C: -1.46%
conference
Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033 - Novel Approach to Cancer Therapy Might Offer a Promising Market Opportunity to ASO Therapeutics
Published: 2023-12-21 (Crawled : 23:00) - prnewswire.com
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 0.45%
H: 4.0%
C: 1.78%
report cancer therapeutics therapy market
Geron Announces IMerge Phase 3 Presentations at ASH Highlighting Significant Durability of Transfusion Independence and Breadth of Effect Across MDS Subgroups with Imetelstat in Lower Risk MDS
Published: 2023-12-11 (Crawled : 00:00) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -6.76%
transfusion durability risk
Geron Announces Fifty Percent Enrollment in the Phase 3 IMpactMF Clinical Trial Evaluating Imetelstat in Patients with Relapsed/Refractory Myelofibrosis
Published: 2023-12-06 (Crawled : 13:30) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 1.02%
H: 3.03%
C: 0.51%
trial
Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS
Published: 2023-12-04 (Crawled : 11:00) - biospace.com/
GERN | $3.66 4.57% 2.5M
|
Health Technology
|
| O: 5.53%
H: 0.48%
C: -11.43%
lancet publication risk trial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3686 142.02% 76M
|
Consumer Services
CZOO | $11.685 134.17% 7.6M
|
BOF | $1.93 64.96% 55M
|
AMST | $3.14 57.0% 59M
|
Technology Services
LICN | $0.7885 40.8% 11M
|
TROO | $1.51 38.53% 5.6M
|
Manufacturing
MULN | News | $3.7 35.53% 6.4M
|
Information
WHLM | $6.61 30.12% 400K
|
Commercial Services
RILY | $27.91 28.5% 8.9M
|
Finance
RBBN 4 | $3.25 26.46% 1.5M
|
Electronic Technology
Last 48 Hours Insiders Buying
MNSB P 310 | $15.785 -3.52% 7.8K
|
Finance
|
15:30
TPL P 3 | $585.24 -0.44% 8K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 3.1K
|
Finance and Insurance
|
15:01
MEGI | $11.97 -0.08% 42K
|
|
00:30
CTRN P 29000 | $22.445 0.97% 16K
|
Retail Trade
|
22:00
CONN | $3.75 1.35% 19K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.565 -0.48% 210K
|
Finance
|
17:30
RMCF | $3.54 410
|
Consumer Non-Durables
|
20:10